{"hands_on_practices": [{"introduction": "The resting membrane potential is the foundation of neuronal excitability, determined by a delicate balance of ion concentrations and membrane permeabilities. This balance can be disrupted in pathological states, leading to the hyperexcitability that underpins seizures. This exercise [@problem_id:4834407] challenges you to apply the Goldman-Hodgkin-Katz equation to quantify how an increase in extracellular potassium, a common occurrence during seizure activity, shifts the membrane potential toward the threshold for firing.", "problem": "A cortical pyramidal neuron at rest exhibits selective membrane permeabilities to potassium, sodium, and chloride that reflect the dominance of leak channels. In seizure activity, extracellular potassium concentration often rises because of intense neuronal firing and limited astrocytic buffering, which can depolarize neurons and promote hyperexcitability. Assume the membrane is thin, isopotential, and obeys the constant-field (uniform electric field) approximation for ion movement.\n\nStarting from the Nernst–Planck description of ionic flux under an electric field and diffusion, and invoking steady state at rest (net ionic current equals zero) for the dominant monovalent ions potassium, sodium, and chloride, derive an expression for the resting membrane potential $V_{m}$ in terms of absolute temperature $T$, the universal gas constant $R$, the Faraday constant $F$, the intracellular and extracellular ion activities $[K^{+}]_{i}$, $[Na^{+}]_{i}$, $[Cl^{-}]_{i}$, $[K^{+}]_{o}$, $[Na^{+}]_{o}$, $[Cl^{-}]_{o}$, and the absolute permeabilities $P_{K}, P_{Na}, P_{Cl}$. State clearly any sign conventions you use for $V_{m}$ and valences.\n\nThen, using the derived expression, compute $V_{m}$ for the following typical neuronal conditions at physiological temperature:\n- Temperature: $T = 310\\,\\mathrm{K}$, gas constant $R = 8.314\\,\\mathrm{J\\,mol^{-1}\\,K^{-1}}$, Faraday constant $F = 96485\\,\\mathrm{C\\,mol^{-1}}$.\n- Relative permeabilities: $P_{K} : P_{Na} : P_{Cl} = 1 : 0.04 : 0.45$ (you may set $P_{K} = 1$ and scale the others accordingly).\n- Intracellular activities: $[K^{+}]_{i} = 140\\,\\mathrm{mM}$, $[Na^{+}]_{i} = 12\\,\\mathrm{mM}$, $[Cl^{-}]_{i} = 7\\,\\mathrm{mM}$.\n- Baseline extracellular activities: $[K^{+}]_{o} = 3\\,\\mathrm{mM}$, $[Na^{+}]_{o} = 140\\,\\mathrm{mM}$, $[Cl^{-}]_{o} = 120\\,\\mathrm{mM}$.\n\nNext, predict the new resting membrane potential when extracellular potassium rises to $[K^{+}]_{o} = 8\\,\\mathrm{mM}$ while all other quantities remain unchanged. Finally, report the depolarizing shift $\\Delta V_{m}$ defined as $V_{m}([K^{+}]_{o} = 8\\,\\mathrm{mM}) - V_{m}([K^{+}]_{o} = 3\\,\\mathrm{mM})$.\n\nRound your final numerical result for $\\Delta V_{m}$ to three significant figures and express it in $\\mathrm{mV}$. Do not include a percentage sign in any part of your answer. Angles are not involved in this problem.", "solution": "The user-provided problem is assessed to be valid. It is scientifically grounded in the established principles of membrane biophysics, namely the Nernst-Planck equation and the constant-field model, which together lead to the Goldman-Hodgkin-Katz (GHK) equation. The problem is well-posed, providing all necessary physical constants, initial conditions (ion activities, permeabilities), and a clear set of tasks. The values provided are physiologically realistic for a mammalian neuron. The question is objective and free of any speculative or non-scientific claims.\n\nThe first step is to derive the expression for the resting membrane potential, $V_m$, from the Nernst-Planck description of ionic flux. The Nernst-Planck equation describes the flux density $J_s$ of an ion species $s$ due to diffusion and an electric field:\n$$J_s(x) = -D_s \\left( \\frac{dC_s(x)}{dx} + \\frac{z_s F}{RT} C_s(x) \\frac{d\\phi(x)}{dx} \\right)$$\nHere, $D_s$ is the diffusion coefficient of the ion in the membrane, $C_s(x)$ is the ion activity at position $x$ within the membrane, $z_s$ is the ion's valence, $F$ is the Faraday constant, $R$ is the universal gas constant, $T$ is the absolute temperature, and $\\phi(x)$ is the electric potential.\n\nWe adopt the sign convention where the membrane potential $V_m$ is the potential inside relative to the outside, i.e., $V_m = \\phi_{in} - \\phi_{out}$. We set the outside potential to zero, so $\\phi_{out} = 0$, and $\\phi_{in} = V_m$. We define the coordinate system such that $x=0$ corresponds to the extracellular side and $x=L$ corresponds to the intracellular side, where $L$ is the membrane thickness.\n\nThe problem states to assume a constant electric field across the membrane. This implies that the potential gradient $d\\phi/dx$ is constant:\n$$\\frac{d\\phi(x)}{dx} = \\frac{\\phi(L) - \\phi(0)}{L} = \\frac{V_m - 0}{L} = \\frac{V_m}{L}$$\nSubstituting this into the Nernst-Planck equation gives:\n$$J_s = -D_s \\left( \\frac{dC_s}{dx} + \\frac{z_s F V_m}{RTL} C_s \\right)$$\nAt steady state, the flux $J_s$ for each ion is constant across the membrane. This is a first-order linear ordinary differential equation for $C_s(x)$. Rearranging:\n$$\\frac{dC_s}{dx} + \\left(\\frac{z_s F V_m}{RTL}\\right) C_s = -\\frac{J_s}{D_s}$$\nTo solve this ODE, we integrate across the membrane from $x=0$ to $x=L$, with boundary conditions $C_s(0) = [s]_o$ and $C_s(L) = [s]_i$. The solution for the flux $J_s$ is:\n$$J_s = -P_s \\left(\\frac{z_s F V_m}{RT}\\right) \\frac{[s]_i \\exp\\left(\\frac{z_s F V_m}{RT}\\right) - [s]_o}{\\exp\\left(\\frac{z_s F V_m}{RT}\\right) - 1}$$\nwhere the membrane permeability $P_s$ is defined as $P_s = D_s/L$ (assuming the partition coefficient is unity).\n\nAt steady state (resting potential), the net ionic current across the membrane is zero. The total current density $I_{tot}$ is the sum of the individual ionic current densities, $I_s = z_s F J_s$.\n$$I_{tot} = I_K + I_{Na} + I_{Cl} = 0$$\n$$F z_K J_K + F z_{Na} J_{Na} + F z_{Cl} J_{Cl} = 0$$\nSince $z_K = +1$, $z_{Na} = +1$, and $z_{Cl} = -1$, and we can divide by $F$:\n$$J_K + J_{Na} - J_{Cl} = 0$$\nSubstituting the expression for $J_s$ for each ion and canceling the common non-zero factor of $-V_m F/RT$:\n$$P_K \\frac{[K^+]_i e^{FV_m/RT} - [K^+]_o}{e^{FV_m/RT}-1} + P_{Na} \\frac{[Na^+]_i e^{FV_m/RT} - [Na^+]_o}{e^{FV_m/RT}-1} + P_{Cl} \\frac{[Cl^-]_i e^{-FV_m/RT} - [Cl^-]_o}{e^{-FV_m/RT}-1} = 0$$\nLet $u = \\exp(FV_m/RT)$. The third term for chloride can be rewritten:\n$$P_{Cl} \\frac{[Cl^-]_i u^{-1} - [Cl^-]_o}{u^{-1}-1} = P_{Cl} \\frac{([Cl^-]_i - [Cl^-]_o u)/u}{(1-u)/u} = P_{Cl} \\frac{[Cl^-]_i - [Cl^-]_o u}{1-u} = -P_{Cl} \\frac{[Cl^-]_i - [Cl^-]_o u}{u-1}$$\nSubstituting this back into the sum:\n$$ P_K([K^+]_i u - [K^+]_o) + P_{Na}([Na^+]_i u - [Na^+]_o) - P_{Cl}([Cl^-]_i - [Cl^-]_o u) = 0 $$\nGrouping terms with $u$:\n$$ u(P_K[K^+]_i + P_{Na}[Na^+]_i + P_{Cl}[Cl^-]_o) = P_K[K^+]_o + P_{Na}[Na^+]_o + P_{Cl}[Cl^-]_i $$\nSolving for $u$:\n$$ u = \\exp\\left(\\frac{FV_m}{RT}\\right) = \\frac{P_K[K^+]_o + P_{Na}[Na^+]_o + P_{Cl}[Cl^-]_i}{P_K[K^+]_i + P_{Na}[Na^+]_i + P_{Cl}[Cl^-]_o} $$\nFinally, solving for $V_m$ yields the Goldman-Hodgkin-Katz (GHK) voltage equation:\n$$ V_m = \\frac{RT}{F} \\ln\\left( \\frac{P_K[K^+]_o + P_{Na}[Na^+]_o + P_{Cl}[Cl^-]_i}{P_K[K^+]_i + P_{Na}[Na^+]_i + P_{Cl}[Cl^-]_o} \\right) $$\n\nNow we proceed to the numerical calculation. First, we compute the pre-factor $RT/F$:\n$$ \\frac{RT}{F} = \\frac{(8.314\\,\\mathrm{J\\,mol^{-1}\\,K^{-1}})(310\\,\\mathrm{K})}{96485\\,\\mathrm{C\\,mol^{-1}}} \\approx 0.026712\\,\\mathrm{V} $$\nThe relative permeabilities are given as $P_K : P_{Na} : P_{Cl} = 1 : 0.04 : 0.45$. We can use these ratios directly in the GHK equation, setting $P_K=1$, $P_{Na}=0.04$, and $P_{Cl}=0.45$.\n\nFor the baseline condition ([K$^+$]$_o = 3\\,\\mathrm{mM}$):\n- Intracellular activities: $[K^{+}]_{i} = 140\\,\\mathrm{mM}$, $[Na^{+}]_{i} = 12\\,\\mathrm{mM}$, $[Cl^{-}]_{i} = 7\\,\\mathrm{mM}$.\n- Extracellular activities: $[K^{+}]_{o} = 3\\,\\mathrm{mM}$, $[Na^{+}]_{o} = 140\\,\\mathrm{mM}$, $[Cl^{-}]_{o} = 120\\,\\mathrm{mM}$.\n\nThe argument of the logarithm is:\n$$ \\text{Arg}_1 = \\frac{(1)(3) + (0.04)(140) + (0.45)(7)}{(1)(140) + (0.04)(12) + (0.45)(120)} = \\frac{3 + 5.6 + 3.15}{140 + 0.48 + 54} = \\frac{11.75}{194.48} $$\nSo the baseline membrane potential, $V_{m,1}$, is:\n$$ V_{m,1} = (0.026712\\,\\mathrm{V}) \\ln\\left(\\frac{11.75}{194.48}\\right) \\approx (0.026712\\,\\mathrm{V}) \\times (-2.8066) \\approx -0.07497\\,\\mathrm{V} = -74.97\\,\\mathrm{mV} $$\n\nNext, for the condition of elevated extracellular potassium ($[K^{+}]_{o} = 8\\,\\mathrm{mM}$), while all other values remain constant:\nThe argument of the logarithm becomes:\n$$ \\text{Arg}_2 = \\frac{(1)(8) + (0.04)(140) + (0.45)(7)}{(1)(140) + (0.04)(12) + (0.45)(120)} = \\frac{8 + 5.6 + 3.15}{194.48} = \\frac{16.75}{194.48} $$\nThe new membrane potential, $V_{m,2}$, is:\n$$ V_{m,2} = (0.026712\\,\\mathrm{V}) \\ln\\left(\\frac{16.75}{194.48}\\right) \\approx (0.026712\\,\\mathrm{V}) \\times (-2.4519) \\approx -0.06549\\,\\mathrm{V} = -65.49\\,\\mathrm{mV} $$\n\nFinally, we compute the depolarizing shift $\\Delta V_m$:\n$$ \\Delta V_m = V_{m,2} - V_{m,1} = (-65.49\\,\\mathrm{mV}) - (-74.97\\,\\mathrm{mV}) = 9.48\\,\\mathrm{mV} $$\nAlternatively, and more precisely, we can calculate $\\Delta V_m$ as:\n$$ \\Delta V_m = \\frac{RT}{F} \\left( \\ln(\\text{Arg}_2) - \\ln(\\text{Arg}_1) \\right) = \\frac{RT}{F} \\ln\\left(\\frac{\\text{Arg}_2}{\\text{Arg}_1}\\right) $$\n$$ \\Delta V_m = \\frac{RT}{F} \\ln\\left(\\frac{16.75/194.48}{11.75/194.48}\\right) = \\frac{RT}{F} \\ln\\left(\\frac{16.75}{11.75}\\right) $$\n$$ \\Delta V_m \\approx (0.026712\\,\\mathrm{V}) \\ln(1.42553) \\approx (0.026712\\,\\mathrm{V})(0.35455) \\approx 0.009468\\,\\mathrm{V} = 9.468\\,\\mathrm{mV} $$\nRounding the result to three significant figures, the depolarizing shift is $9.47\\,\\mathrm{mV}$.", "answer": "$$\\boxed{9.47}$$", "id": "4834407"}, {"introduction": "While typically inhibitory, the action of GABA depends critically on the electrochemical gradient for chloride ions. In the developing brain, different ion transporter expressions can lead to high intracellular chloride, making GABAergic transmission depolarizing and paradoxically excitatory. This practice [@problem_id:4834334] delves into this crucial concept by asking you to calculate the precise intracellular chloride concentration at which the GABA response transitions from hyperpolarizing to depolarizing, offering a quantitative window into the unique neurobiology of neonatal seizures.", "problem": "Consider a cortical principal neuron in a neonate with high expression of Sodium-Potassium-Chloride Cotransporter 1 (NKCC1) and low expression of Potassium-Chloride Cotransporter 2 (KCC2), which elevates the intracellular chloride concentration $[\\mathrm{Cl}^{-}]_i$. Activation of Gamma-Aminobutyric Acid type A (GABA$_{\\text{A}}$) receptors opens primarily chloride-selective channels, so the reversal potential for the GABA$_{\\text{A}}$ conductance is approximated by the chloride equilibrium potential $E_{\\mathrm{Cl}}$. Whether GABA$_{\\text{A}}$ activation is depolarizing or hyperpolarizing at rest is determined by the sign of the driving force $V_{\\mathrm{rest}} - E_{\\mathrm{Cl}}$.\n\nStarting from the equality of electrochemical potentials at equilibrium for an ion of valence $z$ across a membrane, derive the chloride equilibrium potential $E_{\\mathrm{Cl}}$ in terms of the universal gas constant $R$, absolute temperature $T$, Faraday’s constant $F$, and the extracellular and intracellular chloride activities, which for this problem may be treated as concentrations $[\\mathrm{Cl}^{-}]_o$ and $[\\mathrm{Cl}^{-}]_i$. Then, using the derived expression and the values $V_{\\mathrm{rest}} = -65\\,\\mathrm{mV}$, $[\\mathrm{Cl}^{-}]_o = 130\\,\\mathrm{mM}$, $T = 310\\,\\mathrm{K}$, $z = -1$, $R = 8.314\\,\\mathrm{J\\,mol^{-1}\\,K^{-1}}$, and $F = 96485\\,\\mathrm{C\\,mol^{-1}}$, compute the critical intracellular chloride concentration $[\\mathrm{Cl}^{-}]_i^{*}$ at which $E_{\\mathrm{Cl}} = V_{\\mathrm{rest}}$ and the GABA$_{\\text{A}}$ current at rest changes sign (the developmental switch between depolarizing and hyperpolarizing GABA action). Assume bicarbonate permeability is negligible for this calculation.\n\nExpress your final numerical answer for $[\\mathrm{Cl}^{-}]_i^{*}$ in millimolar (mM) and round it to four significant figures.", "solution": "The problem is subjected to validation before a solution is attempted.\n\n### Step 1: Extract Givens\n- **Context**: A cortical principal neuron in a neonate with high Sodium-Potassium-Chloride Cotransporter 1 (NKCC1) and low Potassium-Chloride Cotransporter 2 (KCC2) expression.\n- **Condition**: Intracellular chloride concentration, $[\\mathrm{Cl}^{-}]_i$, is elevated.\n- **Approximation**: The reversal potential for GABA$_{\\text{A}}$ conductance is approximated by the chloride equilibrium potential, $E_{\\mathrm{Cl}}$.\n- **Driving Force**: The sign of the GABA$_{\\text{A}}$ current at rest is determined by $V_{\\mathrm{rest}} - E_{\\mathrm{Cl}}$.\n- **Task 1**: Derive the chloride equilibrium potential $E_{\\mathrm{Cl}}$ starting from the equality of electrochemical potentials. The derivation should be in terms of the universal gas constant $R$, absolute temperature $T$, Faraday’s constant $F$, and the concentrations $[\\mathrm{Cl}^{-}]_o$ and $[\\mathrm{Cl}^{-}]_i$.\n- **Task 2**: Compute the critical intracellular chloride concentration $[\\mathrm{Cl}^{-}]_i^{*}$ at which $E_{\\mathrm{Cl}} = V_{\\mathrm{rest}}$.\n- **Assumption**: Bicarbonate permeability is negligible. Ion activities may be treated as concentrations.\n- **Given Values**:\n  - $V_{\\mathrm{rest}} = -65\\,\\mathrm{mV}$\n  - $[\\mathrm{Cl}^{-}]_o = 130\\,\\mathrm{mM}$\n  - $T = 310\\,\\mathrm{K}$\n  - $z = -1$ for chloride ions.\n  - $R = 8.314\\,\\mathrm{J\\,mol^{-1}\\,K^{-1}}$\n  - $F = 96485\\,\\mathrm{C\\,mol^{-1}}$\n- **Final Answer Format**: Numerical value for $[\\mathrm{Cl}^{-}]_i^{*}$ in millimolar (mM), rounded to four significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is assessed for validity.\n- **Scientific Grounding**: The problem is scientifically sound. It describes the well-established developmental switch of GABAergic signaling due to changes in intracellular chloride regulation by NKCC1 and KCC2 transporters. The use of the Nernst equation to determine an ion's equilibrium potential is a fundamental principle of cellular electrophysiology.\n- **Well-Posedness**: The problem is well-posed. It provides all necessary information and a clear objective: to derive an equation and then use it to calculate a specific quantity under a well-defined condition ($E_{\\mathrm{Cl}} = V_{\\mathrm{rest}}$). A unique solution can be determined.\n- **Objectivity**: The problem is stated in objective, formal language without subjective or ambiguous terms.\n- **Consistency and Completeness**: The provided values are physically realistic and dimensionally consistent. The assumptions are clearly stated and appropriate for a textbook-style problem.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid** as it is scientifically grounded, well-posed, objective, and self-contained. A full solution will be provided.\n\nThe first step is to derive the Nernst equation for the chloride equilibrium potential, $E_{\\mathrm{Cl}}$. At equilibrium, the net flow of an ion across the membrane is zero. This occurs when the electrochemical potential for the ion is equal on both sides of the membrane. The electrochemical potential, $\\mu$, for an ionic species is the sum of its chemical potential and its electrical potential energy.\n\nFor an ion with charge $zF$ per mole, the electrochemical potential on one side of the membrane is given by:\n$$ \\mu = \\mu^0 + RT \\ln(a) + zFV $$\nwhere $\\mu^0$ is the standard chemical potential, $R$ is the universal gas constant, $T$ is the absolute temperature, $a$ is the activity of the ion (approximated here by concentration), $z$ is the valence of the ion, $F$ is Faraday's constant, and $V$ is the electrical potential.\n\nAt equilibrium, the electrochemical potential inside the cell ($\\mu_i$) equals that outside the cell ($\\mu_o$):\n$$ \\mu_i = \\mu_o $$\n$$ \\mu^0 + RT \\ln([\\mathrm{Cl}^{-}]_i) + z_{\\mathrm{Cl}}FV_i = \\mu^0 + RT \\ln([\\mathrm{Cl}^{-}]_o) + z_{\\mathrm{Cl}}FV_o $$\nThe standard potential $\\mu^0$ is identical on both sides and cancels out. Rearranging the terms to solve for the potential difference across the membrane, $E_{\\mathrm{Cl}} = V_i - V_o$:\n$$ z_{\\mathrm{Cl}}F(V_i - V_o) = RT \\ln([\\mathrm{Cl}^{-}]_o) - RT \\ln([\\mathrm{Cl}^{-}]_i) $$\n$$ z_{\\mathrm{Cl}}F E_{\\mathrm{Cl}} = RT \\ln\\left(\\frac{[\\mathrm{Cl}^{-}]_o}{[\\mathrm{Cl}^{-}]_i}\\right) $$\nThe equilibrium potential $E_{\\mathrm{Cl}}$ is therefore:\n$$ E_{\\mathrm{Cl}} = \\frac{RT}{z_{\\mathrm{Cl}}F} \\ln\\left(\\frac{[\\mathrm{Cl}^{-}]_o}{[\\mathrm{Cl}^{-}]_i}\\right) $$\nFor chloride ions, the valence is $z_{\\mathrm{Cl}} = -1$. Substituting this value:\n$$ E_{\\mathrm{Cl}} = \\frac{RT}{(-1)F} \\ln\\left(\\frac{[\\mathrm{Cl}^{-}]_o}{[\\mathrm{Cl}^{-}]_i}\\right) $$\nUsing the logarithmic identity $-\\ln(x) = \\ln(1/x)$, we obtain the final form for the derivation:\n$$ E_{\\mathrm{Cl}} = \\frac{RT}{F} \\ln\\left(\\frac{[\\mathrm{Cl}^{-}]_i}{[\\mathrm{Cl}^{-}]_o}\\right) $$\nThis expression gives the chloride equilibrium potential as a function of the specified parameters.\n\nThe second part of the problem requires finding the critical intracellular chloride concentration, $[\\mathrm{Cl}^{-}]_i^{*}$, at which the resting GABA$_{\\text{A}}$ response switches from depolarizing to hyperpolarizing. This switch point occurs when the GABA$_{\\text{A}}$ reversal potential, $E_{\\mathrm{Cl}}$, is exactly equal to the resting membrane potential, $V_{\\mathrm{rest}}$. At this point, the driving force, $V_{\\mathrm{rest}} - E_{\\mathrm{Cl}}$, is zero.\nWe set the condition $E_{\\mathrm{Cl}} = V_{\\mathrm{rest}}$:\n$$ V_{\\mathrm{rest}} = \\frac{RT}{F} \\ln\\left(\\frac{[\\mathrm{Cl}^{-}]_i^{*}}{[\\mathrm{Cl}^{-}]_o}\\right) $$\nTo solve for $[\\mathrm{Cl}^{-}]_i^{*}$, we rearrange the equation:\n$$ \\frac{V_{\\mathrm{rest}}F}{RT} = \\ln\\left(\\frac{[\\mathrm{Cl}^{-}]_i^{*}}{[\\mathrm{Cl}^{-}]_o}\\right) $$\nExponentiating both sides with base $e$:\n$$ \\exp\\left(\\frac{V_{\\mathrm{rest}}F}{RT}\\right) = \\frac{[\\mathrm{Cl}^{-}]_i^{*}}{[\\mathrm{Cl}^{-}]_o} $$\nFinally, we isolate $[\\mathrm{Cl}^{-}]_i^{*}$:\n$$ [\\mathrm{Cl}^{-}]_i^{*} = [\\mathrm{Cl}^{-}]_o \\exp\\left(\\frac{V_{\\mathrm{rest}}F}{RT}\\right) $$\nNow, we substitute the given numerical values into this expression. It is critical to ensure all units are in the SI system for consistency. The resting potential is given as $V_{\\mathrm{rest}} = -65\\,\\mathrm{mV}$, which is $-65 \\times 10^{-3}\\,\\mathrm{V}$.\nThe given values are:\n$V_{\\mathrm{rest}} = -65 \\times 10^{-3}\\,\\mathrm{V}$\n$[\\mathrm{Cl}^{-}]_o = 130\\,\\mathrm{mM}$\n$R = 8.314\\,\\mathrm{J\\,mol^{-1}\\,K^{-1}}$\n$T = 310\\,\\mathrm{K}$\n$F = 96485\\,\\mathrm{C\\,mol^{-1}}$\n\nFirst, calculate the value of the exponent:\n$$ \\frac{V_{\\mathrm{rest}}F}{RT} = \\frac{(-65 \\times 10^{-3}\\,\\mathrm{V}) \\times (96485\\,\\mathrm{C\\,mol^{-1}})}{(8.314\\,\\mathrm{J\\,mol^{-1}\\,K^{-1}}) \\times (310\\,\\mathrm{K})} $$\nThe numerator is $-6271.525\\,\\mathrm{J\\,mol^{-1}}$ and the denominator is $2577.34\\,\\mathrm{J\\,mol^{-1}}$. The exponent is a dimensionless quantity, as required.\n$$ \\frac{V_{\\mathrm{rest}}F}{RT} = \\frac{-6271.525}{2577.34} \\approx -2.43315 $$\nNow, substitute this back into the expression for $[\\mathrm{Cl}^{-}]_i^{*}$:\n$$ [\\mathrm{Cl}^{-}]_i^{*} = (130\\,\\mathrm{mM}) \\times \\exp(-2.43315) $$\n$$ [\\mathrm{Cl}^{-}]_i^{*} \\approx (130\\,\\mathrm{mM}) \\times 0.0877594 $$\n$$ [\\mathrm{Cl}^{-}]_i^{*} \\approx 11.40872\\,\\mathrm{mM} $$\nRounding the result to four significant figures, as requested:\n$$ [\\mathrm{Cl}^{-}]_i^{*} \\approx 11.41\\,\\mathrm{mM} $$", "answer": "$$\\boxed{11.41}$$", "id": "4834334"}, {"introduction": "Managing epilepsy often involves complex drug regimens, where understanding pharmacokinetics is essential for patient safety and treatment efficacy. The steady-state plasma concentration of an anti-epileptic drug, $C_{ss}$, is a direct function of its dosing rate ($R$) and clearance from the body ($Cl$). This problem [@problem_id:4834339] presents a clinically vital scenario, challenging you to calculate how the addition of one drug can induce the metabolism of another, thereby lowering its concentration and potentially leading to breakthrough seizures.", "problem": "A patient with drug-resistant focal epilepsy is stabilized on a constant-rate oral extended-release formulation of lamotrigine that approximates zero-order input. Assume a one-compartment model with linear pharmacokinetics and time-invariant parameters within each condition. The dosing rate is $R = 24\\,\\mathrm{mg}\\,\\mathrm{h}^{-1}$, and the baseline systemic clearance is $Cl_{\\text{baseline}} = 2.0\\,\\mathrm{L}\\,\\mathrm{h}^{-1}$. Two weeks after adding carbamazepine, a known inducer of hepatic cytochrome P450 (CYP) enzymes, the lamotrigine clearance increases by a fraction $0.60$ relative to baseline due to enzyme induction. Under the assumptions that steady state is achieved and the dosing rate $R$ is unchanged, derive from mass balance and the definition of clearance the steady-state concentration expression, and then determine the new steady-state plasma concentration $C_{\\text{ss,new}}$ after induction. Express your final answer in $\\mathrm{mg}\\,\\mathrm{L}^{-1}$ and round your answer to four significant figures.", "solution": "The problem is first validated to ensure it is scientifically grounded, well-posed, and objective.\n\n**1. Extraction of Givens:**\n- Model: One-compartment, linear pharmacokinetics, time-invariant parameters.\n- Input: Zero-order approximation, constant dosing rate $R = 24\\,\\mathrm{mg}\\,\\mathrm{h}^{-1}$.\n- Baseline Clearance: $Cl_{\\text{baseline}} = 2.0\\,\\mathrm{L}\\,\\mathrm{h}^{-1}$.\n- Clearance Change: Increases by a fraction $f_{\\text{increase}} = 0.60$ relative to baseline.\n- Condition: Steady state is achieved both before and after the change in clearance.\n- Objective: Derive the steady-state concentration expression and determine the new steady-state plasma concentration, $C_{\\text{ss,new}}$.\n\n**2. Validation:**\nThe problem is scientifically sound. It employs a standard one-compartment pharmacokinetic model, a cornerstone of pharmacology. The concepts of zero-order input, clearance, steady state, and enzyme induction (specifically the well-documented interaction where carbamazepine induces the metabolism of lamotrigine) are all fundamental and correctly applied principles. The provided data values are plausible and dimensionally consistent. The problem is well-posed, providing all necessary information to calculate a unique solution. The language is objective and precise.\n\n**3. Verdict:**\nThe problem is valid and can be solved as stated.\n\n**Derivation and Solution:**\n\nThe fundamental principle governing the amount of a drug, $A$, in a one-compartment model over time, $t$, is the mass balance equation:\n$$\n\\frac{dA(t)}{dt} = \\text{Rate of Input} - \\text{Rate of Elimination}\n$$\nThe amount of drug in the body is related to the plasma concentration, $C(t)$, and the volume of distribution, $V_d$, by $A(t) = V_d \\cdot C(t)$. Assuming $V_d$ is constant, the rate of change of the amount is $V_d \\frac{dC(t)}{dt}$.\n\nThe rate of input is given as a constant (zero-order) dosing rate, $R$.\nThe rate of elimination in a linear pharmacokinetic model is the product of the total systemic clearance, $Cl$, and the plasma concentration, $C(t)$.\nSubstituting these terms into the mass balance equation gives the governing differential equation for the system:\n$$\nV_d \\frac{dC(t)}{dt} = R - Cl \\cdot C(t)\n$$\nThe problem specifies that the system reaches steady state. At steady state, the concentration is constant, which means its rate of change with respect to time is zero:\n$$\n\\frac{dC_{\\text{ss}}}{dt} = 0\n$$\nApplying this condition to the differential equation yields:\n$$\n0 = R - Cl \\cdot C_{\\text{ss}}\n$$\nThis equation expresses the core principle of steady state: the rate of drug input equals the rate of drug elimination. Rearranging for the steady-state concentration, $C_{\\text{ss}}$, we derive the general expression:\n$$\nC_{\\text{ss}} = \\frac{R}{Cl}\n$$\nThis is the required expression derived from mass balance.\n\nNext, we apply this expression to the specific conditions of the problem. We are given the baseline clearance, $Cl_{\\text{baseline}} = 2.0\\,\\mathrm{L}\\,\\mathrm{h}^{-1}$.\nAfter the addition of carbamazepine, the clearance increases by a fraction of $0.60$ relative to this baseline. The new clearance, $Cl_{\\text{new}}$, is therefore:\n$$\nCl_{\\text{new}} = Cl_{\\text{baseline}} + (0.60 \\cdot Cl_{\\text{baseline}}) = Cl_{\\text{baseline}} \\cdot (1 + 0.60) = 1.60 \\cdot Cl_{\\text{baseline}}\n$$\nSubstituting the numerical value for the baseline clearance:\n$$\nCl_{\\text{new}} = 1.60 \\cdot (2.0\\,\\mathrm{L}\\,\\mathrm{h}^{-1}) = 3.2\\,\\mathrm{L}\\,\\mathrm{h}^{-1}\n$$\nNow we can calculate the new steady-state concentration, $C_{\\text{ss,new}}$, using the derived formula with the new clearance value and the unchanged dosing rate, $R = 24\\,\\mathrm{mg}\\,\\mathrm{h}^{-1}$.\n$$\nC_{\\text{ss,new}} = \\frac{R}{Cl_{\\text{new}}} = \\frac{24\\,\\mathrm{mg}\\,\\mathrm{h}^{-1}}{3.2\\,\\mathrm{L}\\,\\mathrm{h}^{-1}}\n$$\nPerforming the division:\n$$\nC_{\\text{ss,new}} = 7.5\\,\\mathrm{mg}\\,\\mathrm{L}^{-1}\n$$\nThe problem requires the final answer to be expressed to four significant figures. Therefore, we write the result as $7.500\\,\\mathrm{mg}\\,\\mathrm{L}^{-1}$.", "answer": "$$\\boxed{7.500}$$", "id": "4834339"}]}